American Association of Clinical Endocrinologists and American College of Endocrinology - clinical practice guidelines for developing a diabetes mellitus comprehensive care plan - 2015
Open accessThe DOI matches its Crossref record; 648 of the 651 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“AACE followed a rigorous developmental process based on strict methodology to systematically collect, objectively evaluate, and clearly summarize available scientific literature to develop trustworthy recommendations for clinical practice regarding care of persons with DM.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1]
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
(2004) · The Lancet · doi:10.1016/s0140-6736(03)15268-3 · Cited by 12,717
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Stratton, I. M. (2000) · BMJ · doi:10.1136/bmj.321.7258.405 · Cited by 9,059
KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease
Stevens, P. E., Ahmed, S. B., Carrero, J. J., Foster, B., Francis, A., Hall, R. K., Herrington, W. G., Hill, G., Inker, L. A., Kazancıoğlu, R., et al. (2024) · Kidney International · doi:10.1016/j.kint.2023.10.018 · Cited by 8,530
Research works printed but not linked: 6
- Glucose tolerance and mortality: comparison of WHO and American Diabetic Association diagnostic criteria, 1999, The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe, Lancet, 354, 617
- Disease, 2012, KDIGO clinical practice guideline for anemia in chronic kidney disease, Kidney Int Suppl, 2, 279
- Cheer, 2009, Managing complica- tions of the diabetic foot. BMJ., 339, b4905
- 1996, Neurology, 46, 873
- Heron, 2009, Deaths: final data for 2006, Natl Vital Stat Rep., 57, 1
- 2010, Insulin Infusion Pumps Panel Information.
Cited by
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Self-citationInsel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Self-citationGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2016) · Endocrine Practice · doi:10.4158/ep151126.cs · Cited by 878
Self-citationPratley, R. E., Aroda, V. R., Lingvay, I., Lüdemann, J., Andreassen, C., Navarria, A., & Viljoen, A. (2018) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(18)30024-x · Cited by 790
Polonsky, W., & Henry, R. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s106821 · Cited by 784
Self-citationMechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2020) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2019.10.025 · Cited by 608
Self-citationGarber, A. J., Handelsman, Y., Grunberger, G., Einhorn, D., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bush, M. A., DeFronzo, R. A., Garber, J. R., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2019-0472 · Cited by 598
Self-citationBariatric surgery for obesity and metabolic disorders: state of the art
Nguyen, N. T., & Varela, J. E. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2016.170 · Cited by 505
Mechanick, J. I., Apovian, C., Brethauer, S., Garvey, W. T., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah-Pollack, R., Seger, J., et al. (2019) · Endocrine Practice · doi:10.4158/gl-2019-0406 · Cited by 510
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citationGarber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2018) · Endocrine Practice · doi:10.4158/cs-2017-0153 · Cited by 502
Self-citationAhrén, B., Masmiquel, L., Kumar, H., Sargin, M., Karsbøl, J. D., Jacobsen, S. H., & Chow, F. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(17)30092-x · Cited by 495
US Preventive Services Task Force, Davidson, K. W., Barry, M. J., Mangione, C. M., Cabana, M., Caughey, A. B., Davis, E. M., Donahue, K. E., Doubeni, C. A., Krist, A. H., et al. (2021) · JAMA · doi:10.1001/jama.2021.12531 · Cited by 480
Brain health: time matters in multiple sclerosis
Giovannoni, G., Butzkueven, H., Dhib-Jalbut, S., Hobart, J., Kobelt, G., Pepper, G., Sormani, M. P., Thalheim, C., Traboulsee, A., & Vollmer, T. (2016) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2016.07.003 · Cited by 458
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2017) · Endocrine Practice · doi:10.4158/ep161682.cs · Cited by 435
Self-citationNauck, M. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12591 · Cited by 429
Mechanick, J. I., Apovian, C., Brethauer, S., Timothy Garvey, W., Joffe, A. M., Kim, J., Kushner, R. F., Lindquist, R., Pessah‐Pollack, R., Seger, J., et al. (2020) · Obesity · doi:10.1002/oby.22719 · Cited by 389
Self-citationCapehorn, M. S., Catarig, A.-M., Furberg, J. K., Janez, A., Price, H. C., Tadayon, S., Vergès, B., & Marre, M. (2020) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.101117 · Cited by 412
Frías, J. P., Guja, C., Hardy, E., Ahmed, A., Dong, F., Öhman, P., & Jabbour, S. A. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30267-4 · Cited by 398
Dipeptidyl peptidase 4 inhibitors in the treatment of type 2 diabetes mellitus
Deacon, C. F. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-020-0399-8 · Cited by 398
Agiostratidou, G., Anhalt, H., Ball, D., Blonde, L., Gourgari, E., Harriman, K. N., Kowalski, A. J., Madden, P., McAuliffe-Fogarty, A. H., McElwee-Malloy, M., et al. (2017) · Diabetes Care · doi:10.2337/dc17-1624 · Cited by 397
Self-citationGlucagon-Like Peptide 1 Receptor Agonists for Type 2 Diabetes
Hinnen, D. (2017) · Diabetes Spectrum · doi:10.2337/ds16-0026 · Cited by 394
Zinman, B., Bhosekar, V., Busch, R., Holst, I., Ludvik, B., Thielke, D., Thrasher, J., Woo, V., & Philis-Tsimikas, A. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30066-x · Cited by 376
Handelsman, Y., Henry, R. R., Bloomgarden, Z. T., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Ferrannini, E., Fonseca, V. A., Garber, A. J., Grunberger, G., et al. (2016) · Endocrine Practice · doi:10.4158/ep161292.ps · Cited by 358
Self-citationDrug-microbiota interactions: an emerging priority for precision medicine
Zhao, Q., Chen, Y., Huang, W., Zhou, H., & Zhang, W. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01619-w · Cited by 268
Garber, A. J., Abrahamson, M. J., Barzilay, J. I., Blonde, L., Bloomgarden, Z. T., Bush, M. A., Dagogo-Jack, S., DeFronzo, R. A., Einhorn, D., Fonseca, V. A., et al. (2019) · Endocrine Practice · doi:10.4158/cs-2018-0535 · Cited by 297
Self-citationGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161356.esgl · Cited by 283
Self-citationNRF2 activation by antioxidant antidiabetic agents accelerates tumor metastasis
Wang, H., Liu, X., Long, M., Huang, Y., Zhang, L., Zhang, R., Zheng, Y., Liao, X., Wang, Y., Liao, Q., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad6095 · Cited by 286
Grunberger, G., Sherr, J., Allende, M., Blevins, T., Bode, B., Handelsman, Y., Hellman, R., Lajara, R., Roberts, V. L., Rodbard, D., et al. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2021.04.008 · Cited by 288
Self-citationDiabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
Self-citationHandelsman, Y., Jellinger, P. S., Guerin, C. K., Bloomgarden, Z. T., Brinton, E. A., Budoff, M. J., Davidson, M. H., Einhorn, D., Fazio, S., Fonseca, V. A., et al. (2020) · Endocrine Practice · doi:10.4158/cs-2020-0490 · Cited by 248
Self-citationEmpagliflozin for Type 2 Diabetes Mellitus: An Overview of Phase 3 Clinical Trials
Levine, M. J. (2017) · Current Diabetes Reviews · doi:10.2174/1573399812666160613113556 · Cited by 230
A history of continuous glucose monitors (CGMs) in self-monitoring of diabetes mellitus
Olczuk, D., & Priefer, R. (2018) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2017.09.005 · Cited by 194
Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Bansilal, S., Bhatt, D. L., Leiter, L. A., et al. (2018) · American Heart Journal · doi:10.1016/j.ahj.2018.01.012 · Cited by 181
RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020
Madhu, S., Chawla, R., Makkar, B., Ghosh, S., Saboo, B., & Kalra, S. (2020) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_225_20 · Cited by 167
EADSG Guidelines: Insulin Therapy in Diabetes
Silver, B., Ramaiya, K., Andrew, S. B., Fredrick, O., Bajaj, S., Kalra, S., Charlotte, B. M., Claudine, K., & Makhoba, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0384-6 · Cited by 179
Role of Physical Activity for Weight Loss and Weight Maintenance
Cox, C. E. (2017) · Diabetes Spectrum · doi:10.2337/ds17-0013 · Cited by 167
Hackett, G., Kirby, M., Edwards, D., Jones, T. H., Wylie, K., Ossei-Gerning, N., David, J., & Muneer, A. (2017) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2017.10.067 · Cited by 143
van Iersel, L., Brokke, K. E., Adan, R. A. H., Bulthuis, L. C. M., van den Akker, E. L. T., & van Santen, H. M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00017 · Cited by 146
Fruchart, J.-C., Santos, R. D., Aguilar-Salinas, C., Aikawa, M., Al Rasadi, K., Amarenco, P., Barter, P. J., Ceska, R., Corsini, A., Després, J.-P., et al. (2019) · Cardiovascular Diabetology · doi:10.1186/s12933-019-0864-7 · Cited by 140
Kaku, K., Yamada, Y., Watada, H., Abiko, A., Nishida, T., Zacho, J., & Kiyosue, A. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13218 · Cited by 132
RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017
Bajaj, S. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0604-7 · Cited by 125
Bailey, T. S., Grunberger, G., Bode, B. W., Handelsman, Y., Hirsch, I. B., Jovanovič, L., Roberts, V. L., Rodbard, D., Tamborlane, W. V., & Walsh, J. S. A. (2016) · Endocrine Practice · doi:10.4158/ep151124.cs · Cited by 149
Self-citationSeino, Y., Terauchi, Y., Osonoi, T., Yabe, D., Abe, N., Nishida, T., Zacho, J., & Kaneko, S. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13082 · Cited by 127
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
Thrasher, J. (2017) · The American Journal of Medicine · doi:10.1016/j.amjmed.2017.04.004 · Cited by 112
McCoy, R. G., Dykhoff, H. J., Sangaralingham, L., Ross, J. S., Karaca-Mandic, P., Montori, V. M., & Shah, N. D. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0213 · Cited by 122
Pharmacologic Management of Type 2 Diabetes Mellitus: Available Therapies
Thrasher, J. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.05.009 · Cited by 112
Shared decision making in endocrinology: Present and future directions
Rodriguez-Gutierrez, R., Gionfriddo, M. R., Ospina, N. S., Maraka, S., Tamhane, S., Montori, V. M., & Brito, J. P. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00468-4 · Cited by 117
Breaking Bad News: An Evidence-Based Review of Communication Models for Oncology Nurses
Bumb, M., Keefe, J., Miller, L., & Overcash, J. A. (2017) · Clinical journal of oncology nursing · doi:10.1188/17.cjon.573-580 · Cited by 141
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes
Markmann, J. F., Rickels, M. R., Eggerman, T. L., Bridges, N. D., Lafontant, D. E., Qidwai, J., Foster, E., Clarke, W. R., Kamoun, M., Alejandro, R., et al. (2021) · American Journal of Transplantation · doi:10.1111/ajt.16174 · Cited by 111
Diabetic Sensory and Motor Neuropathy
Vinik, A. I. (2016) · New England Journal of Medicine · doi:10.1056/nejmcp1503948 · Cited by 113
Self-citationCardiometabolic-Based Chronic Disease, Addressing Knowledge and Clinical Practice Gaps
Mechanick, J. I., Farkouh, M. E., Newman, J. D., & Garvey, W. T. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.11.046 · Cited by 113
Self-citationGiagulli, V. A., Carbone, M. D., Ramunni, M. I., Licchelli, B., De Pergola, G., Sabbà, C., Guastamacchia, E., & Triggiani, V. (2015) · Andrology · doi:10.1111/andr.12099 · Cited by 109
Mechanick, J. I., Garber, A. J., Grunberger, G., Handelsman, Y., & Garvey, W. T. (2018) · Endocrine Practice · doi:10.4158/ps-2018-0139 · Cited by 104
Self-citationHandelsman, Y., Butler, J., Bakris, G. L., DeFronzo, R. A., Fonarow, G. C., Green, J. B., Grunberger, G., Januzzi, J. L., Klein, S., Kushner, P. R., et al. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108389 · Cited by 119
Self-citationSystematic Nutritional Support in Allogeneic Hematopoietic Stem Cell Transplant Recipients
Fuji, S., Einsele, H., Savani, B. N., & Kapp, M. (2015) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2015.07.003 · Cited by 116
Treating pain in diabetic neuropathy: current and developmental drugs
Alam, U., Sloan, G., & Tesfaye, S. (2020) · Drugs · doi:10.1007/s40265-020-01259-2 · Cited by 104
Kalra, S., Bahendeka, S., Sahay, R., Ghosh, S., Md, F., Orabi, A., Ramaiya, K., Al Shammari, S., Shrestha, D., Shaikh, K., et al. (2018) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_556_17 · Cited by 101
The Current Drug Treatment Landscape for Diabetes and Perspectives for the Future
Bailey, C. (2015) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.144 · Cited by 102
Future glucose-lowering drugs for type 2 diabetes
Bailey, C. J., Tahrani, A. A., & Barnett, A. H. (2016) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00462-3 · Cited by 112
Hackett, G. I., Kirby, M. G., Rees, R. W., Jones, T. H., Muneer, A., Livingston, M. A., Ossei‐Gerning, N., David, J., Foster, J., Kalra, P. A., et al. (2023) · The World Journal of Men s Health · doi:10.5534/wjmh.221027 · Cited by 107
Alteration of gut microbiota induced by DPP-4i treatment improves glucose homeostasis
Liao, X., Song, L., Zeng, B., Liu, B., Qiu, Y., Qu, H., Zheng, Y., Long, M., Zhou, H., Wang, Y., et al. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.03.057 · Cited by 103
Iraqi Experts Consensus on the Management of Type 2 Diabetes/Prediabetes in Adults
Abusaib, M., Ahmed, M. J., Nwayyir, H. A., Alidrisi, H. A., Alabbood, M., Albayati, A. H., AL-Ibrahimi, S. M., Al-Kharasani, A. M. R., Alrubaye, H. F., Mahwi, T., et al. (2020) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551420942232 · Cited by 121
Teneligliptin in management of type 2 diabetes mellitus
Swami, O. C., Sharma, S. K., Panneerselvam, A., Singh, K. P., Parmar, G., & Gadge, P. V. (2016) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s106133 · Cited by 91
Chu, D., Wu, J., Wang, K., Zhao, M., Wang, C., Li, L., & Guo, R. (2018) · BMC Cancer · doi:10.1186/s12885-018-4334-5 · Cited by 90
Association of Hemoglobin A1c and Wound Healing in Diabetic Foot Ulcers
Fesseha, B., Abularrage, C. J., Hines, K. F., Sherman, R. L., Frost, P., Langan, S. J., Canner, J. K., Likes, K. C., Hosseini, S. M., Jack, G. A., et al. (2018) · Diabetes Care · doi:10.2337/dc17-1683 · Cited by 93
Ausili, D., Rebora, P., Di Mauro, S., Riegel, B., Valsecchi, M. G., Paturzo, M., Alvaro, R., & Vellone, E. (2016) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2016.08.006 · Cited by 79
Litchman, M. L., Lewis, D., Kelly, L. A., & Gee, P. M. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818795705 · Cited by 85
Management of Adults With Diabetes and Cognitive Problems
Hopkins, R. L., Shaver, K., & Weinstock, R. S. (2016) · Diabetes Spectrum · doi:10.2337/ds16-0035 · Cited by 91
Lingvay, I., Desouza, C. V., Lalic, K. S., Rose, L., Hansen, T., Zacho, J., & Pieber, T. R. (2018) · Diabetes Care · doi:10.2337/dc17-2381 · Cited by 81
New biomarkers for diagnosis and management of polycystic ovary syndrome
Karakas, S. E. (2017) · Clinica Chimica Acta · doi:10.1016/j.cca.2017.06.009 · Cited by 89
Therapeutic medications against diabetes: What we have and what we expect
Hu, C., & Jia, W. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.11.008 · Cited by 89
Burton‐Freeman, B. M., Brzeziński, M., Park, E., Sandhu, A. K., Xiao, D., & Edirisinghe, I. (2019) · Nutrients · doi:10.3390/nu11040841 · Cited by 86
Madsbad, S. (2015) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2015.09.019 · Cited by 84
Shared decision‐making in the care of individuals with diabetes
Serrano, V., Rodriguez‐Gutierrez, R., Hargraves, I., Gionfriddo, M. R., Tamhane, S., & Montori, V. M. (2016) · Diabetic Medicine · doi:10.1111/dme.13143 · Cited by 75
Ausili, D., Bulgheroni, M., Ballatore, P., Specchia, C., Ajdini, A., Bezze, S., Mauro, S. D., & Genovese, S. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1035-5 · Cited by 87
All Patients Should Be Screened for Diabetes Before Total Joint Arthroplasty
Shohat, N., Goswami, K., Tarabichi, M., Sterbis, E., Tan, T. L., & Parvizi, J. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.047 · Cited by 80
Review of Metformin Use for Type 2 Diabetes Prevention
Moin, T., Schmittdiel, J. A., Flory, J. H., Yeh, J., Karter, A. J., Kruge, L. E., Schillinger, D., Mangione, C. M., Herman, W. H., & Walker, E. A. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.038 · Cited by 75
Mata‐Cases, M., Franch‐Nadal, J., Real, J., Gratacòs, M., López‐Simarro, F., Khunti, K., & Mauricio, D. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13045 · Cited by 72
Apovian, C. M., Garvey, W. T., & Ryan, D. H. (2015) · Obesity · doi:10.1002/oby.21140 · Cited by 72
Self-citationShestakova, M. V., & Александровна, Ю. Е. (2015) · Diabetes Mellitus · doi:10.14341/dm20151s1-112 · Cited by 71
Paramasivam, S. S., Chinna, K., Singh, A. K. K., Ratnasingam, J., Ibrahim, L., Lim, L. L., Tan, A. T. B., Chan, S. P., Tan, P. C., Omar, S. Z., et al. (2018) · Diabetic Medicine · doi:10.1111/dme.13649 · Cited by 69
Risk factors and outcomes of macrosomia in China: a multicentric survey based on birth data
Wang, D., Hong, Y., Zhu, L., Wang, X., Lv, Q., Zhou, Q., Ruan, M., & Chen, C. (2016) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2016.1252746 · Cited by 76
Minimizing Glycemic Fluctuations in Patients with Type 2 Diabetes: Approaches and Importance
Dandona, P. (2017) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0372 · Cited by 67
Cardiovascular safety of anti-diabetic drugs
Kumar, R. B., Kerins, D. M., & Walther, T. (2015) · European Heart Journal - Cardiovascular Pharmacotherapy · doi:10.1093/ehjcvp/pvv035 · Cited by 72
The Treatment of Painful Diabetic Neuropathy
SLOAN, G. P., Alam, U., Selvarajah, D., & Tesfaye, S. H. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210707112413 · Cited by 71
Rosenblit, P. D. (2016) · Cardiovascular Diabetology · doi:10.1186/s12933-016-0412-7 · Cited by 75
Self-citationImpact of sodium–glucose cotransporter 2 inhibitors on blood pressure
Reed, J. (2016) · Vascular Health and Risk Management · doi:10.2147/vhrm.s111991 · Cited by 64
Acute Wound Complications After Total Knee Arthroplasty: Prevention and Management
Simons, M., Amin, N. H., & Scuderi, G. R. (2017) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-15-00402 · Cited by 65
Controlled release of biologics for the treatment of type 2 diabetes
Gilroy, C. A., Luginbuhl, K. M., & Chilkoti, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.002 · Cited by 67
Kalra, S., Das, A. K., Sahay, R. K., Baruah, M. P., TIWASKAR, M. H., Das, S., Chatterjee, S., Saboo, B., Bantwal, G., Bhattacharya, S., et al. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0669-4 · Cited by 70
PPAR-α agonists are still on the rise: an update on clinical and experimental findings
Ferri, N., Corsini, A., Sirtori, C., & Ruscica, M. (2017) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2017.1312339 · Cited by 55
Busch, R. S., & Kane, M. P. (2017) · Postgraduate Medicine · doi:10.1080/00325481.2017.1342509 · Cited by 57
Lifestyle intervention for morbid obesity: effects on liver steatosis, inflammation, and fibrosis
Hohenester, S. D., Christiansen, S., Nagel, J. M., Wimmer, R., Artmann, R., Denk, G., Bischoff, M., Bischoff, G., & Rust, C. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00044.2018 · Cited by 60
Practical Approach to Initiating SGLT2 Inhibitors in Type 2 Diabetes
Peralta, F. G., Abreu, C., Lecube, A., Bellido, D., Soto, A., Morales, C., Brito-Sanfiel, M. Á., & Umpierrez, G. E. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0277-0 · Cited by 67
Self-citationDNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
Raciti, G. A., Desiderio, A., Longo, M., Leone, A., Zatterale, F., Prevenzano, I., Miele, C., Napoli, R., & Bèguinot, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111652 · Cited by 66
Bode, B. W., & Garg, S. K. (2015) · Endocrine Practice · doi:10.4158/ep15869.ra · Cited by 56
Triglycerides, Atherosclerosis, and Cardiovascular Outcome Studies: Focus on Omega-3 Fatty Acids
Handelsman, Y., & Shapiro, M. D. (2016) · Endocrine Practice · doi:10.4158/ep161445.ra · Cited by 60
Self-citationPrevalence of Nonalcoholic Fatty Liver Disease in the Female Population
Arshad, T., Golabi, P., Paik, J. M., Mishra, A., & Younossi, Z. M. (2018) · Hepatology Communications · doi:10.1002/hep4.1285 · Cited by 59
Metadata
- Authors
- Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O. P., Garber, A. J., Garvey, W. T., Henry, R. R., Hirsch, I. B., Horton, E. S., Hurley, D. L., Jellinger, P. S., Jovanovič, L., Lebovitz, H. E., LeRoith, D., Levy, P., McGill, J. B., Mechanick, J. I., Mestman, J. H., Moghissi, E. S., Orzeck, E. A., Pessah-Pollack, R., Rosenblit, P. D., Vinik, A. I., Wyne, K., & Zangeneh, F.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Wayne State University (US)
- Emory University (US)
- Cleveland Clinic (US)
- Ochsner Medical Center (US)
- Louisiana State University (US)
- University of Tennessee Health Science Center (US)
- American Association of Clinical Endocrinologists (US)
- Joslin Diabetes Center (US)
- Harvard University (US)
- University of Alabama at Birmingham (US)
- University of Washington (US)
- Mayo Clinic (US)
- University of Southern California (US)
- State University of New York (US)
- University of Arizona (US)
- Washington University in St. Louis (US)
- University of California, Los Angeles (US)
- University of California, Irvine (US)
- Eastern Virginia Medical School (US)
- Houston Methodist (US)
- Corresponding author
- Zangeneh, Farhad
- ORCID
- Handelsman, Yehuda
- Bloomgarden, Zachary T.
- Grunberger, George
- Umpierrez, Guillermo
- Zimmerman, Robert S.
- Bailey, Timothy S.
- Blonde, Lawrence
- Bray, George A.
- Dagogo-Jack, Samuel
- Davidson, Jaime A.
- Einhorn, Daniel
- Ganda, Om P.
- Garvey, W. Timothy
- Henry, Robert R.
- Hirsch, Irl B.
- Horton, Edward S.
- Hurley, Daniel L.
- McGill, Janet B.
- Mechanick, Jeffrey I.
- Vinik, Aaron I.
- Wyne, Kathleen
- Venue
- Endocrine Practice
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 21
- Pages
- 1-87
- ISSN
- 1530-891X (ISSN-L)
- OpenAlex
- W4240794548
- Cited by
- 559
- References
- 651
- Citations by year
- 2026: 5 · 2025: 3 · 2024: 20 · 2023: 22 · 2022: 41 · 2021: 41 · 2020: 67 · 2019: 62 · 2018: 86 · 2017: 77 · 2016: 93 · 2015: 40
- FWCI
- 85.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Endocrine Practice (publishedVersion)
- Funders
- Abbott Laboratories
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Novartis
- Sanofi
- F. Hoffmann-La Roche
- Regeneron Pharmaceuticals
- Asahi Kasei Pharma Corporation
- Zoetis
- Amarin Corporation
- Novo Nordisk
- St. Jude Medical
- Janssen Pharmaceuticals
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- diabetes mellitus, comprehensive care plan, diabetes management, clinical decision-making, patient-centered care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.